Pyuria resident survival guide: Difference between revisions
No edit summary |
|||
(8 intermediate revisions by 2 users not shown) | |||
Line 19: | Line 19: | ||
__NOTOC__ | __NOTOC__ | ||
{{WikiDoc CMG}}; {{AE}} {{Ibtisam}} | {{WikiDoc CMG}}; {{AE}} {{Ibtisam}} {{Sahar}} | ||
{{SK}} Approach to pyuria, Pyuria workup, Pyuria management | {{SK}} Approach to pyuria, Pyuria workup, Pyuria management | ||
Line 182: | Line 182: | ||
==Treatment== | ==Treatment== | ||
Shown below are the algorithms summarizing the treatment of pyuria.<ref name="Wise2005">{{cite journal|last1=Wise|first1=Gilbert J|title=Genitourinary fungal infections: a therapeutic conundrum|journal=Expert Opinion on Pharmacotherapy|volume=2|issue=8|year=2005|pages=1211–1226|issn=1465-6566|doi=10.1517/14656566.2.8.1211}}</ref> | Shown below are the algorithms summarizing the treatment of pyuria.<ref name="Wise2005">{{cite journal|last1=Wise|first1=Gilbert J|title=Genitourinary fungal infections: a therapeutic conundrum|journal=Expert Opinion on Pharmacotherapy|volume=2|issue=8|year=2005|pages=1211–1226|issn=1465-6566|doi=10.1517/14656566.2.8.1211}}</ref> | ||
It typically depends on the specific cause of pyuria. | It typically depends on the specific [[cause]] of pyuria. | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | A01 |A01='''[[Gonorrhea]]''' <br> and <br> '''[[Chlamydia]]''' }} | {{familytree | | | | | | | | A01 |A01='''[[Gonorrhea]]''' <br> and <br> '''[[Chlamydia]]''' }} | ||
{{familytree | | | | | | | | |!| | | | | | }} | {{familytree | | | | | | | | |!| | | | | | }} | ||
{{familytree | | | | | | | | A'01| | | | | | A'01= NAAT <br> with first-catch <br> urine sample}} | {{familytree | | | | | | | | A'01| | | | | | A'01= '''[[NAAT|NAAT]]''' <br> with first-catch <br> [[urine]] sample}} | ||
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | {{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | ||
{{familytree | | | B01 | | | | | | | | B02 | | |B01=Positive |B02=Negative }} | {{familytree | | | B01 | | | | | | | | B02 | | |B01=Positive |B02=Negative }} | ||
{{familytree | |,|-|^|.| | | | | | | | |!| }} | {{familytree | |,|-|^|.| | | | | | | | |!| }} | ||
{{familytree | D01 | | D02 | | | | | | D03 |D01=Gonorrhea |D02=Chlamydia |D03= Evaluate for <br> other causes }} | {{familytree | D01 | | D02 | | | | | | D03 |D01=[[Gonorrhea]] |D02=[[Chlamydia]] |D03= Evaluate for <br> other [[causes]] }} | ||
{{familytree | |!| | | |!| | | | | | | | | | | }} | {{familytree | |!| | | |!| | | | | | | | | | | }} | ||
{{familytree | E01 | | E'01| | | | | | | | | |E01=Ceftriaxone '''250mg''' <br> Intramuscularly <br> and either <br> Azithromycin '''1g''' <br> Orally <br> Doxycycline '''100mg''' <br> Orally <br> twice a day <br> for 7 days |E'01= Azithromycin '''1g''' <br> Orally <br> Doxycycline '''100mg''' <br> Orally <br> twice a day <br> for 7 days <br> Alternatively <br> Erythromycin '''500mg''' <br> Four times a day <br> for 7 days }} | {{familytree | E01 | | E'01| | | | | | | | | |E01=[[Ceftriaxone]] '''250mg''' <br> Intramuscularly <br> and either <br> [[Azithromycin]] '''1g''' <br> Orally <br> [[Doxycycline]] '''100mg''' <br> Orally <br> twice a day <br> for 7 days |E'01= [[Azithromycin]] '''1g''' <br> Orally <br> [[Doxycycline]] '''100mg''' <br> Orally <br> twice a day <br> for 7 days <br> Alternatively <br> [[Erythromycin]] '''500mg''' <br> Four times a day <br> for 7 days }} | ||
{{familytree | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | | | | | }} | ||
{{familytree/end}} | {{familytree/end}} | ||
'''Abbreviations''': '''NAAT''': [[NAAT|Nucleic Acid Amplification Test]] | |||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | A01 |A01= '''Fungal Infections''' }} | {{familytree | | | | A01 |A01= '''[[Fungal]] Infections''' }} | ||
{{familytree | |,|-|-|^|-|-|.| | | | }} | {{familytree | |,|-|-|^|-|-|.| | | | }} | ||
{{familytree | A'01| | | | A02| | | | A'01= Antifungal drugs: <br> Fluconazole,<br> Posaconazole,<br> Echinocandins and <br> Amphotericin B | A02= '''[[Candida albicans]]''': <br> Fluconazole 100 mg PO<br> qd for 2-5 days }} | {{familytree | A'01| | | | A02| | | | A'01= [[Antifungal]] drugs: <br> [[Fluconazole]],<br> [[Posaconazole]],<br> [[Echinocandins]] and <br> [[Amphotericin B]] | A02= '''[[Candida albicans]]''': <br> [[Fluconazole]] 100 mg PO<br> qd for 2-5 days }} | ||
{{familytree | |!| | | | | |!| | | }} | {{familytree | |!| | | | | |!| | | }} | ||
{{familytree | B01 | | | | B02| | |B01= If the patient has <br> coexisting diabetes | {{familytree | B01 | | | | B02| | |B01= If the [[patient]] has <br> coexisting [[diabetes mellitus]] or<br> immunosuppression | B02= '''Non-albicans Candida''':<br> [[Amphotericin B]] <br> 0.1 mg/kg/day IV<br> for 2-5 days }} | ||
{{familytree | |!| | | | | | | | | | }} | {{familytree | |!| | | | | | | | | | }} | ||
{{familytree | D01 | | | | | | | | |D01= More than one <br> Antifungal drugs <br>+<br> Antibiotics }} | {{familytree | D01 | | | | | | | | |D01= More than one <br> [[Antifungal]] drugs <br>+<br> [[Antibiotics]] }} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 211: | Line 211: | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | A01 |A01= '''Renal Tuberculosis''' }} | {{familytree | | | | A01 |A01= '''[[Renal]] [[Tuberculosis]]''' }} | ||
{{familytree | | | | |!| | | | | | }} | {{familytree | | | | |!| | | | | | }} | ||
{{familytree | | | | A'01| | | | | | A'01= Isoniazid 300 mg PO qd for 2 months <br>AND<br> Rifampicin 450-600 mg qd for 2 months <br>AND<br> Ethambutol 15-25 mg/kg PO qd for 2 months <br>AND <br>Pyrazinamide 1500 mg for 2 months <br>THEN<br> Isoniazid 300 mg PO qd for 4-6 months <br>AND<br> Rifampicin 450-600 mg qd for 4-6 months}} | {{familytree | | | | A'01| | | | | | A'01= [[Isoniazid]] 300 mg PO qd for 2 months <br>AND<br> [[Rifampicin]] 450-600 mg qd for 2 months <br>AND<br> [[Ethambutol]] 15-25 mg/kg PO qd for 2 months <br>AND <br>[[Pyrazinamide]] 1500 mg for 2 months <br>THEN<br> [[Isoniazid]] 300 mg PO qd for 4-6 months <br>AND<br> [[Rifampicin]] 450-600 mg qd for 4-6 months}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 220: | Line 220: | ||
{{familytree | | | | | | A01 |A01= '''[[Trichomoniasis]]''' }} | {{familytree | | | | | | A01 |A01= '''[[Trichomoniasis]]''' }} | ||
{{familytree | | | | | | |!| | | | | | }} | {{familytree | | | | | | |!| | | | | | }} | ||
{{familytree | | | | | | A'01| | | | | | A'01= Preferred regimen: <br> Metronidazole 2 g PO<br> single dose <br>OR<br> Tinidazole 2 g PO <br> single dose}} | {{familytree | | | | | | A'01| | | | | | A'01= Preferred regimen: <br> [[Metronidazole]] 2 g PO<br> single dose <br>OR<br> [[Tinidazole]] 2 g PO <br> single dose}} | ||
{{familytree | | | | | | |!| | | | | | }} | {{familytree | | | | | | |!| | | | | | }} | ||
{{familytree | | | | | | A02 | | | | | | | A02=Treat | {{familytree | | | | | | A02 | | | | | | | A02=Treat [[patient]]’s sex partner<br> if [[trichomoniasis]]<br> is diagnosed in [[patient]]}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 229: | Line 229: | ||
{{familytree | | | | A01 |A01= '''[[Genital herpes]]''' }} | {{familytree | | | | A01 |A01= '''[[Genital herpes]]''' }} | ||
{{familytree | | | | |!| | | | | | }} | {{familytree | | | | |!| | | | | | }} | ||
{{familytree | | | | A'01| | | | | | A'01= Preferred regimen: <br> Acyclovir 400 mg PO tid for 7–10 days <br>OR<br> Acyclovir 200 mg PO five times a day<br> for 7–10 days<br>OR<br> Famciclovir 250 mg PO tid for 7–10 days <br>OR <br>Valacyclovir 1 g PO bid for 7 days}} | {{familytree | | | | A'01| | | | | | A'01= Preferred regimen: <br> [[Acyclovir]] 400 mg PO tid for 7–10 days <br>OR<br> [[Acyclovir]] 200 mg PO five times a day<br> for 7–10 days<br>OR<br> [[Famciclovir]] 250 mg PO tid for 7–10 days <br>OR <br>[[Valacyclovir]] 1 g PO bid for 7 days}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 236: | Line 236: | ||
{{familytree | | | | | A01 |A01= '''[[Mycoplasma]] and [[Ureaplasma]]''' }} | {{familytree | | | | | A01 |A01= '''[[Mycoplasma]] and [[Ureaplasma]]''' }} | ||
{{familytree | | | | | |!| | | | | | }} | {{familytree | | | | | |!| | | | | | }} | ||
{{familytree | | | | | A'01| | | | | | A'01= Preferred regimen: <br> Azithromycin <br> OR <br> Levofloxacin <br>OR<br> Moxifloxacin}} | {{familytree | | | | | A'01| | | | | | A'01= Preferred regimen: <br> [[Azithromycin]] <br> OR <br> [[Levofloxacin]] <br>OR<br> [[Moxifloxacin]]}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 243: | Line 243: | ||
{{familytree | | | | | A01 |A01= '''[[Schistosomiasis]]''' }} | {{familytree | | | | | A01 |A01= '''[[Schistosomiasis]]''' }} | ||
{{familytree | | | | | |!| | | | | | }} | {{familytree | | | | | |!| | | | | | }} | ||
{{familytree | | | | | A'01| | | | | | A'01= Preferred regimen: <br> Praziquantel 20 mg/kg PO bid <br>for 1–2 days}} | {{familytree | | | | | A'01| | | | | | A'01= Preferred regimen: <br> [[Praziquantel]] 20 mg/kg PO bid <br>for 1–2 days}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==Do's== | ==Do's== | ||
Evaluate for | Evaluate for [[sexually transmitted diseases]], if [[risk factors]] are present including unprotected sexual encounters.<ref name="GungorBeji2011">{{cite journal|last1=Gungor|first1=Ilkay|last2=Beji|first2=Nezihe Kizilkaya|title=Lifestyle changes for the prevention and management of lower urinary tract symptoms in women|journal=International Journal of Urological Nursing|volume=5|issue=1|year=2011|pages=3–13|issn=17497701|doi=10.1111/j.1749-771X.2011.01112.x}}</ref><br> | ||
Instruct the female [[patients]] to: | |||
*Lose weight (if they are overweight or obese). | *Lose weight (if they are overweight or obese). | ||
*Always stay hydrated. | *Always stay hydrated. | ||
Line 259: | Line 259: | ||
==Don'ts== | ==Don'ts== | ||
*Do not give [[fluoroquinolones]] in pregnancy. | *Do not give [[fluoroquinolones]] in [[pregnancy]]. | ||
*Don't give [[TMP-SMX]] in the first trimester or near term of pregnancy. | *Don't give [[TMP-SMX]] in the first trimester or near term of [[pregnancy]]. | ||
*Delay | *Delay urination. | ||
*Smoke | *Smoke | ||
*Drink the following items | *Drink the following items in excess: | ||
**Caffeinated sodas | **Caffeinated sodas | ||
**Alcohol | **[[Alcohol]] | ||
**Spicy foods | **Spicy foods | ||
**Acidic fruits | **Acidic fruits | ||
Line 272: | Line 272: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category:Up-To-Date]] |
Latest revision as of 18:33, 24 September 2020
Pyuria Resident Survival Guide |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ibtisam Ashraf, M.B.B.S.[2] Sahar Memar Montazerin, M.D.[3]
Synonyms and keywords: Approach to pyuria, Pyuria workup, Pyuria management
Overview
Pyuria is a urinary condition characterized by a high number of white blood cells in the urine. It is generally characterized as the presence of 10 or more white blood cells per cubic millimetre in a sample of urine, 3 or more white cells per high-power field of unspun urine, a positive result on Gram's staining of an unspun urine specimen or a urinary dipstick test that is positive for leukocyte esterase. Pyuria occurs in urinary tract infections (UTI) and/or sepsis. Other causes include sterile pyuria, STDs, pneumonia, interstitial cystitis, kidney stones, pelvic infections and urinary fistulas. Long-term usage of some medications, including aspirin, diuretics, nitrofurantoin, proton pump inhibitors and NSAIDs, induces pyuria. There may be visible changes in the urine, which may appear cloudy or thick or look like pus.
Causes
Life Threatening Causes
Life-threatening causes of pyuria include
Common Causes
- Sterile Pyuria[1]
- Sexually transmitted disease such as chlamydia, gonorrhea, genital herpes, human papilloma virus infection, syphilis and HIV
- Viral Infections such as adenovirus, BK polyomavirus, and cytomegalovirus
- Genitourinary tuberculosis
- Fungal infection such as Candida albicans
- Parasitic infection such as Trichomonas vaginalis
- Interstitial cystitis
- Painful bladder syndrome
- Pelvic infections
- Intra-abdominal infections
- Radiation cystitis
- Pneumonia
- Foreign bodies in the urinary tract
- Transvaginal mesh
- Urinary fistulas
- Intrinsic renal diseases
- Renal transplant rejection
- Polycystic kidney disease
- Kidney stones
- Autoimmune diseases, such as Kawasaki disease
The table below demonstrates the possible causes of pyuria:[2][3]
Common causes of pyuria | |||||
---|---|---|---|---|---|
Non-iInfectious | Infectious | ||||
Medication side effect | Systemic disease | Accompanied with hematuria | History of surgery/radiotherapy | Accompanied with weight loss | Infections |
|
|
Diagnosis
The below algorithms shows primary approach to patients with pyuria:[2]
History and Physical Eexamination Ask for urinary symptoms such as: | |||||||||||||||||||||||||||||||||
Laboratory Investigations Check for urinanalysis and urine cullture | |||||||||||||||||||||||||||||||||
Other Investigations Consider urinary tract ultrasound or computed tomography: | |||||||||||||||||||||||||||||||||
Shown below is an algorithm summarizing the diagnosis of pyuria.[4]
Patient with Pyuria | |||||||||||||||||
Patient with pelvic pain, urinary symptoms and urethral symptoms | Patient with fever, systemic symptoms, urinary symptoms, abdominal or pelvic pain | ||||||||||||||||
Evaluate for: STDs, Prostatitis, PID | Reassess for bacterial infection by means of aerobic and anaerobic culture | ||||||||||||||||
If not detected, consider: Urinary stone, Foreign body, Interstitial cystitis, Bladder tumor, Schistosomiasis | No bacteria detected | ||||||||||||||||
Evaluate for: Tuberculosis If patient is a immigrant from tuberculosis endemic country Fungal infection If patient is immunocompromised, check for candida, aspergillus or cryptococcus infection | |||||||||||||||||
If no infection detected, consult with infectious disease specialist or nephrologist | |||||||||||||||||
Treatment
Shown below are the algorithms summarizing the treatment of pyuria.[5] It typically depends on the specific cause of pyuria.
Gonorrhea and Chlamydia | |||||||||||||||||||||||||||||||||
NAAT with first-catch urine sample | |||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||
Gonorrhea | Chlamydia | Evaluate for other causes | |||||||||||||||||||||||||||||||
Ceftriaxone 250mg Intramuscularly and either Azithromycin 1g Orally Doxycycline 100mg Orally twice a day for 7 days | Azithromycin 1g Orally Doxycycline 100mg Orally twice a day for 7 days Alternatively Erythromycin 500mg Four times a day for 7 days | ||||||||||||||||||||||||||||||||
Abbreviations: NAAT: Nucleic Acid Amplification Test
Fungal Infections | |||||||||||||||||||||||
Antifungal drugs: Fluconazole, Posaconazole, Echinocandins and Amphotericin B | Candida albicans: Fluconazole 100 mg PO qd for 2-5 days | ||||||||||||||||||||||
If the patient has coexisting diabetes mellitus or immunosuppression | Non-albicans Candida: Amphotericin B 0.1 mg/kg/day IV for 2-5 days | ||||||||||||||||||||||
More than one Antifungal drugs + Antibiotics | |||||||||||||||||||||||
Renal Tuberculosis | |||||||||||||||||||||
Isoniazid 300 mg PO qd for 2 months AND Rifampicin 450-600 mg qd for 2 months AND Ethambutol 15-25 mg/kg PO qd for 2 months AND Pyrazinamide 1500 mg for 2 months THEN Isoniazid 300 mg PO qd for 4-6 months AND Rifampicin 450-600 mg qd for 4-6 months | |||||||||||||||||||||
Trichomoniasis | |||||||||||||||||||||||||||
Preferred regimen: Metronidazole 2 g PO single dose OR Tinidazole 2 g PO single dose | |||||||||||||||||||||||||||
Treat patient’s sex partner if trichomoniasis is diagnosed in patient | |||||||||||||||||||||||||||
Genital herpes | |||||||||||||||||||||
Preferred regimen: Acyclovir 400 mg PO tid for 7–10 days OR Acyclovir 200 mg PO five times a day for 7–10 days OR Famciclovir 250 mg PO tid for 7–10 days OR Valacyclovir 1 g PO bid for 7 days | |||||||||||||||||||||
Mycoplasma and Ureaplasma | |||||||||||||||||||||||
Preferred regimen: Azithromycin OR Levofloxacin OR Moxifloxacin | |||||||||||||||||||||||
Schistosomiasis | |||||||||||||||||||||||
Preferred regimen: Praziquantel 20 mg/kg PO bid for 1–2 days | |||||||||||||||||||||||
Do's
Evaluate for sexually transmitted diseases, if risk factors are present including unprotected sexual encounters.[6]
Instruct the female patients to:
- Lose weight (if they are overweight or obese).
- Always stay hydrated.
- Urinate after sexual intercourse.
- Always wipe front to back.
- Wear cotton/comfortable underwear.
- Use menstrual cups, sanitary pads, or clean period-proof underwear.
- Maintain personal hygiene.
Don'ts
- Do not give fluoroquinolones in pregnancy.
- Don't give TMP-SMX in the first trimester or near term of pregnancy.
- Delay urination.
- Smoke
- Drink the following items in excess:
- Caffeinated sodas
- Alcohol
- Spicy foods
- Acidic fruits
References
- ↑ Glen P, Prashar A, Hawary A (2016). "Sterile pyuria: a practical management guide". Br J Gen Pract. 66 (644): e225–7. doi:10.3399/bjgp16X684217. PMC 4758505. PMID 26917663.
- ↑ 2.0 2.1 Glen, Peter; Prashar, Akash; Hawary, Amr (2016). "Sterile pyuria: a practical management guide". British Journal of General Practice. 66 (644): e225–e227. doi:10.3399/bjgp16X684217. ISSN 0960-1643.
- ↑ Dieter, Robert S. (2000). "Sterile pyuria: A differential diagnosis". Comprehensive Therapy. 26 (3): 150–152. doi:10.1007/s12019-000-0001-1. ISSN 0098-8243.
- ↑ Wise, Gilbert J.; Longo, Dan L.; Schlegel, Peter N. (2015). "Sterile Pyuria". New England Journal of Medicine. 372 (11): 1048–1054. doi:10.1056/NEJMra1410052. ISSN 0028-4793.
- ↑ Wise, Gilbert J (2005). "Genitourinary fungal infections: a therapeutic conundrum". Expert Opinion on Pharmacotherapy. 2 (8): 1211–1226. doi:10.1517/14656566.2.8.1211. ISSN 1465-6566.
- ↑ Gungor, Ilkay; Beji, Nezihe Kizilkaya (2011). "Lifestyle changes for the prevention and management of lower urinary tract symptoms in women". International Journal of Urological Nursing. 5 (1): 3–13. doi:10.1111/j.1749-771X.2011.01112.x. ISSN 1749-7701.